Calithera Biosciences Inc expected to post a loss of $2.65 a share - Earnings Preview

Calithera Biosciences

12/08/2022 23:57

* Calithera Biosciences Inc  CALA.OQ   CALA.O  is expected
to show
a fall in quarterly revenue when it reports  results on August
15. 
    * ​Refinitiv's mean analyst estimate for Calithera
Biosciences Inc
is for a loss of $2.65 per share. For the same quarter last
year, the company reported a loss of $3.80 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Calithera
Biosciences Inc is $30​, above​ its last closing price of $4.11.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -3.85       -3.70      -3.60     Beat    2.7
 Dec. 31 2022  -5.30       -4.80      -4.80     Met     0
 Sep. 30 2021  -4.42       -4.56      -3.00     Beat    34.2​
 Jun. 30 2021  -4.77       -4.81      -3.80     Beat    20.9
 ​​Mar.        -5.37       -5.52      -5.60     Missed  -1.4
 31 2021                                                
 Dec. 31 2020  -6.60       -6.48      -6.40     Beat    1.2​
 Sep. 30 2020  -6.26       -6.21      -6.40     Missed  -3.1
 Jun. 30 2020  -6.69       -6.69      -5.80     Beat    13.3
 This summary was machine generated August 12 at 22:57 GMT.  All
figures in US dollars  unless otherwise stated